IKBKB and Miyoshi myopathy: Mutations in genes in the NF-κB pathway were observed in 1 of 31 MM samples, which indicates that moderate NF-κB signaling activation by transgenic IKK2 expression in heterozygosity is enough for the development of precursor stages, which progress into MM without additional changes in the pathway.